- Home
- TR vs TLX Comparison
TR vs TLX Comparison
Compare TR & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TR
- TLX
- Stock Information
- Founded
- TR 1896
- TLX 2015
- Country
- TR United States
- TLX Australia
- Employees
- TR N/A
- TLX 554
- Industry
- TR Specialty Foods
- TLX Biotechnology: Pharmaceutical Preparations
- Sector
- TR Consumer Staples
- TLX Health Care
- Exchange
- TR Nasdaq
- TLX Nasdaq
- Market Cap
- TR 2.9B
- TLX 3.0B
- IPO Year
- TR N/A
- TLX N/A
- Fundamental
- Price
- TR $37.88
- TLX $9.11
- Analyst Decision
- TR
- TLX Strong Buy
- Analyst Count
- TR 0
- TLX 4
- Target Price
- TR N/A
- TLX $21.00
- AVG Volume (30 Days)
- TR 177.3K
- TLX 85.2K
- Earning Date
- TR 10-23-2025
- TLX 01-01-0001
- Dividend Yield
- TR 0.95%
- TLX N/A
- EPS Growth
- TR 0.79
- TLX N/A
- EPS
- TR 1.28
- TLX 0.04
- Revenue
- TR $729,620,000.00
- TLX $664,225,558.00
- Revenue This Year
- TR N/A
- TLX N/A
- Revenue Next Year
- TR N/A
- TLX N/A
- P/E Ratio
- TR $30.28
- TLX $214.59
- Revenue Growth
- TR 0.34
- TLX 55.35
- 52 Week Low
- TR $28.67
- TLX $8.76
- 52 Week High
- TR $44.27
- TLX $30.36
- Technical
- Relative Strength Index (RSI)
- TR 42.79
- TLX 37.32
- Support Level
- TR $38.39
- TLX $8.76
- Resistance Level
- TR $40.22
- TLX $9.40
- Average True Range (ATR)
- TR 1.07
- TLX 0.24
- MACD
- TR 0.17
- TLX -0.10
- Stochastic Oscillator
- TR 36.52
- TLX 22.28
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.